Cargando…

Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals

INTRODUCTION: Central nervous system (CNS) penetration-effectiveness (CPE) rank was proposed in 2008 as an estimate of penetration of ARV regimen into the CNS, and validated as predictor of CSF HIV-1 replication. Results on predictive role of CPE on neurocognitive and clinical outcome were conflicti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Libertone, Raffaella, Lorenzini, Patrizia, Balestra, Pietro, Pinnetti, Carmela, Ricottini, Martina, Maddalena Plazzi, Maria, Menichetti, Samanta, Zaccarelli, Mauro, Nicastri, Emanuele, Bellagamba, Rita, Ammassari, Adriana, Antinori, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P123
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225401/ https://www.ncbi.nlm.nih.gov/pubmed/25394159 http://dx.doi.org/10.7448/IAS.17.4.19655

Ejemplares similares

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

Relationship between body mass index and bone mineral density in HIV-infected patients referred for DXA
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis
por: Zaccarelli, Mauro, et al.
Publicado: (2014)

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics
por: Ammassari, Adriana, et al.
Publicado: (2014)

Three-Dimensional Biomechanical Analysis of Rearfoot and Forefoot Running
por: Knorz, Sebastian, et al.
Publicado: (2017)

Impact of COVID-19 on the Patient Enrollment for a Pragmatic, Cluster Randomized Clinical Trial for Fibromyalgia
por: Bayman, Emine O., et al.
Publicado: (2022)

No significant association between patient self-reported non-adherence to antiretrovirals and HIV-tropism: a preliminary analysis
por: Ammassari, A, et al.
Publicado: (2012)

AGENTES ETIOLÓGICOS DE MENINGOENCEFALITE CIRCULANTES DURANTE O PERÍODO DE PANDEMIA DA COVID-19
por: Farias, Luis Arthur Brasil G., et al.
Publicado: (2022)

TRAUMATIC “ANGIOEDEMA”: EXTENSIVE SUBCUTANEOUS EMPHYSEMA MASQUERADING AS ANGIOEDEMA
por: Khakwani, Z., et al.
Publicado: (2022)

Dermatite atopique et psoriasis chez l’enfant et infection à SARS-CoV-2. Impact différent de l’infection sur ces dermatoses, et de ces dermatoses sur l’infection ?
por: Mahé, E., et al.
Publicado: (2022)

Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature
por: Fabbri, Gabriele, et al.
Publicado: (2017)

Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV
por: Mastrorosa, Ilaria, et al.
Publicado: (2022)

Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients
por: Berno, Giulia, et al.
Publicado: (2014)

Darunavir-based dual therapy in HIV experienced patients
por: Sterrantino, Gaetana, et al.
Publicado: (2014)

Prevalence of anal human papillomavirus infection and cytologic abnormalities among HIV-infected and HIV-uninfected men who have sex with men
por: Latini, Alessandra, et al.
Publicado: (2014)

Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals
por: Rozera, Gabriella, et al.
Publicado: (2017)

Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection
por: Mondi, Annalisa, et al.
Publicado: (2022)

Four-drugs regimen containing raltegravir is highly effective in HIV patients starting therapy with >500,000 copies/mL viral load
por: Sterrantino, Gaetana, et al.
Publicado: (2014)

Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors
por: Barber, Tristan J, et al.
Publicado: (2014)

Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era
por: Sterrantino, G, et al.
Publicado: (2012)

HIV in women
por: Mulcahy, F
Publicado: (2012)

Doppler-derived cardiac performance and evaluation of alternative measures of AV conduction to predict unvfavuorable haemodynamics in patients with long PR (DEEPER PR Study)
por: Auge, R E, et al.
Publicado: (2023)

Does optimized daytime/nighttime programming reduce insertable cardiac monitor event burden?
por: Burke, M, et al.
Publicado: (2023)

Adherence in HIV-positive patients treated with single-tablet regimens and multi-pill regimens: findings from the COMPACT study
por: Antinori, A, et al.
Publicado: (2012)

CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study
por: Pérez Valero, Ignacio, et al.
Publicado: (2014)

The Fibrosis-4 index is associated with Intensive Care Unit (ICU) admission in middle-aged patients with COVID-19
por: Biliotti, E., et al.
Publicado: (2021)

Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis
por: Stellbrink, Hans-Juergen, et al.
Publicado: (2014)

Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practice
por: Antinori, Andrea, et al.
Publicado: (2014)

Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naïve patients: analysis of data in the real-world setting in Italy
por: Antinori, Andrea, et al.
Publicado: (2014)

Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort
por: Saracino, Annalisa, et al.
Publicado: (2014)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study
por: Latini, Alessandra, et al.
Publicado: (2016)

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
por: Costarelli, Silvia, et al.
Publicado: (2014)

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Increased incidence of sexually transmitted diseases in the recent years: data from the ICONA cohort
por: Cingolani, Antonella, et al.
Publicado: (2014)

Characterization of HIV-1 subtypes in a Portuguese cohort
por: Rocha Pereira, Nuno, et al.
Publicado: (2014)

The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
por: Amendola, Alessandra, et al.
Publicado: (2020)

Correction: The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
por: Amendola, Alessandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ip4fqb9rqf4j35n576vf8p3lbr